Fennec Pharmaceuticals (FENC) Retained Earnings: 2011-2025
Historic Retained Earnings for Fennec Pharmaceuticals (FENC) over the last 15 years, with Sep 2025 value amounting to -$224.6 million.
- Fennec Pharmaceuticals' Retained Earnings fell 3.19% to -$224.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$224.6 million, marking a year-over-year decrease of 3.19%. This contributed to the annual value of -$219.7 million for FY2024, which is 0.20% down from last year.
- Per Fennec Pharmaceuticals' latest filing, its Retained Earnings stood at -$224.6 million for Q3 2025, which was down 0.28% from -$224.0 million recorded in Q2 2025.
- In the past 5 years, Fennec Pharmaceuticals' Retained Earnings ranged from a high of $215.6 million in Q3 2023 and a low of -$224.6 million during Q3 2025.
- In the last 3 years, Fennec Pharmaceuticals' Retained Earnings had a median value of -$217.7 million in 2024 and averaged -$177.5 million.
- Per our database at Business Quant, Fennec Pharmaceuticals' Retained Earnings spiked by 209.81% in 2023 and then slumped by 200.97% in 2024.
- Quarterly analysis of 5 years shows Fennec Pharmaceuticals' Retained Earnings stood at -$175.1 million in 2021, then decreased by 12.16% to -$203.2 million in 2022, then fell by 7.90% to -$219.2 million in 2023, then fell by 0.20% to -$219.7 million in 2024, then fell by 3.19% to -$224.6 million in 2025.
- Its last three reported values are -$224.6 million in Q3 2025, -$224.0 million for Q2 2025, and -$220.8 million during Q1 2025.